CVS Health Corp vs PPG Industries, Inc. — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while PPG Industries, Inc. trades at $105.43 (market cap $23.44B). The key difference: CVS Health Corp is far larger — about 4.8× PPG Industries, Inc.'s market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and PPG Industries, Inc. for 68 Days on average.
| CVS | PPG | |
|---|---|---|
Market Cap | $112.29B | $23.44B |
Volume | 7,763,676 | 2,064,777 |
Sector | Health | Basic Materials |
52-Week High | $110.60 | $131.56 |
52-Week Low | $70.08 | $94.34 |
Typical Hold Time | 83 Days | 68 Days |
Enterprise Value | $174.64B | $29.31B |
Dividend Yield | 3.03% | 2.81% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
PPG Industries trades at $105.08, down 1.37% on the day, with technical indicators showing bearish momentum. The stock demonstrates solid fundamentals with a P/E of 15.08, net income margin of 9.57%, and strong cash flow generation of $1.94B from operations in 2025. Recent earnings show mixed results with Q1 2026 beating expectations but Q2 2026 missing estimates, while the company maintains its Dividend King status with consistent payouts.
The outlook remains cautiously optimistic with a $130 consensus price target representing 24% upside potential. Key risks include margin pressures in the Automotive Refinish segment and European demand weakness. Analyst consensus leans bullish with 55% buy ratings, though technical weakness suggests potential near-term consolidation before fundamental strength drives recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →